These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864 [TBL] [Abstract][Full Text] [Related]
12. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy. Felix SB; Staudt A; Friedrich GB Autoimmunity; 2001; 34(3):211-5. PubMed ID: 11908780 [TBL] [Abstract][Full Text] [Related]
13. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221 [TBL] [Abstract][Full Text] [Related]
14. Ig apheresis for the treatment of severe DCM patients. Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167 [TBL] [Abstract][Full Text] [Related]
15. Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study. Schimke I; Müller J; Dandel M; Gremmels HD; Bayer W; Wallukat B; Wallukat G; Hetzer R J Clin Apher; 2005 Oct; 20(3):137-42. PubMed ID: 15892087 [TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option. Cavusoglu Y; Tahmazov S; Murat S; Akay OM Rev Assoc Med Bras (1992); 2023; 69(1):90-96. PubMed ID: 36629647 [TBL] [Abstract][Full Text] [Related]
17. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867 [TBL] [Abstract][Full Text] [Related]
18. Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes. Christ T; Adolph E; Schindelhauer S; Wettwer E; Dobrev D; Wallukat G; Ravens U Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):445-52. PubMed ID: 15910408 [TBL] [Abstract][Full Text] [Related]
19. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Staudt A; Schäper F; Stangl V; Plagemann A; Böhm M; Merkel K; Wallukat G; Wernecke KD; Stangl K; Baumann G; Felix SB Circulation; 2001 Jun; 103(22):2681-6. PubMed ID: 11390337 [TBL] [Abstract][Full Text] [Related]
20. [Temporary mechanical left heart support. Recovery of heart function in patients with end-stage idiopathic dilated cardiomyopathy]. Müller J; Wallukat G; Weng YG; Dandel M; Spiegelsberger S; Semrau S; Brandes K; Bieda H; Hummel M; Loebe M; Meyer R; Hetzer R Herz; 1997 Oct; 22(5):227-36. PubMed ID: 9441154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]